REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF β-AR RECEPTORS

摘要

The invention concerns the use of β2-adrenergic modulators for regulating cellular apoptosis (agonists such as clenbuterol, salbutamol, procaterol or isoproterenol or antagonists such as propanolol, ICI 118, 551 or butoxamine) to modulate cellular apoptosis, more particularly hepatic cellular apoptosis.